Rehabilitation has always essentially been about helping patients regain functionality, and Motorika— founded by medical technology entrepreneur Professor Shlomo Ben Haim in 2004—is a company that derives its identity by rewriting this very concept, ‘roboticizing’ it, to be precise. Din Hadass, Motorika Co- CEO explains, “Our ultimate mission is to utilize advanced technologies to provide a world of independence and assist patients in winning back their normal lives through highly improved, intensive, and personalized therapeutic sessions.” The company combines state-of-the-art robotic technologies with its in-depth clinical expertise to “accelerate, optimize, and improve rehabilitation” for patients suffering from neurological disorders, strokes, brain traumas, and orthopedic disabilities.
Motorika improves therapists’ ability to plan and deliver highly efficient, personalized therapeutic rehabilitation to patients through two proprietary ground-breaking robotic based products —ReoGo and ReoAmbulator. Packed with innovative features, the two robots are economical, easy to use, and can be seamlessly monitored by therapists to deliver comprehensive care for patients’ upper and lower body extremities respectively, right from initiation to the final rehabilitation stage. ReoGo facilitates neurologically and orthopedically impaired patients with a portable and user-friendly platform to essentially retrain the motor functionalities of their brains through three dimensional, repetitive upper limb exercises such as movement of hands.
The step-by-step, progressive brain learning training increase muscle-neuron coordination, muscle motion and flexibility, reflexes, sensory reception of limbs, and other functional abilities of the patient that eventually result in much better outcome than traditional physical therapies. The ReoAmbulator is an advanced gait training platform, equipped with treadmills, for ambulatory, non-ambulatory, and orthopedic patients. The system improves patients’ balance, ambulation, muscle coordination, stamina, posture, and overall gait pattern through repetitive and well-monitored exercises and also integrates VR that aims to increase the patient’s engagement, motivation, and awareness. A ReoAmbulator system is currently in clinical trials at Miami Project, at the University of Miami to evaluate the effectiveness of robotic therapy in the rehabilitation of post spinal cord injury patients.
“Our real strength in delivering such breakthrough innovations stems from our deep domain expertise. We have a competent team of clinicians working in R&D that significantly improves our measurement capabilities and closed loop feedback control systems, accumulation of clinical data insights, and delivery of newer features that accurately meet patient needs,” remarks Arik Avni, Motorika’s Co-CEO. Avni explains that to drive breakthrough innovations in medical technology that directly impact and enhance lives, companies should have the ability to unite experts from diverse fields, and “Motorika does exactly that.” In addition to world-class clinicians, Motorika boasts of professionals experienced in software engineering, electronics engineering, algorithm development, mechanical engineering, and marketing fields who work in unison to make the company’s noble mission a reality. The company’s efforts have not gone unnoticed, and Motorika enjoys tremendous success with its two robotic systems all over the globe.
In line with its mission to provide personalized rehabilitation, Motorika now lays its focus on more advanced innovations. The company looks to incorporate cutting-edge technologies in robotics, VR, bio-feedback systems, gait analysis, software algorithms with its clinical expertise to deliver improved and more efficient products.